Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,441
Active & Responsive
A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70
Code: NCT05719441
Phase2, Recruiting
Active & Responsive
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
for
HIV-1-infection
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07645287
Phase2, Recruiting
Active & Responsive
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
for
Long COVID, Sars-CoV-2 Infection, Coronavirus Infections,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Aurora CO,
Sponsor: Wes Ely
Sex: All
Age: 18+
Code: NCT06631287
Phase3, Recruiting
Active & Responsive
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for
Autosomal Dominant Polycystic Kidney Disease
Location: Seattle WA, Boise ID, Idaho Falls ID, San Francisco CA,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18 - 55
Code: NCT06902558
Phase2, Recruiting
Active & Responsive
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Seattle WA, Santa Rosa CA, West Valley City UT,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07277413
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: Seattle WA, Silverdale WA, Corvallis OR, Post Falls ID,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase3, Recruiting
Active & Responsive
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
for
Lymphoma, Non-Hodgkin, B-cell Lymphoma,
Location: Seattle WA, Duarte CA, Denver CO, Aurora CO,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07101328
Phase1, Recruiting
Active & Responsive
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
for
Gastric Adenocarcinoma,
Location: Seattle WA, Orange CA, Westwood KS, Dallas TX,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05365581
Phase1, Recruiting
Active & Responsive
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
for
Colorectal Cancer
Location: Seattle WA, West Valley City UT, Los Angeles CA,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659795
Phase2, Recruiting
Active & Responsive
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
for
Type 1 Diabetes Mellitus, T1D, T1DM,
Location: Seattle WA, Idaho Falls ID, Walnut Creek CA,
Sponsor: COUR Pharmaceutical Development Company, Inc.
Sex: All
Age: 12 - 35
Code: NCT06783309
Phase1, Phase2, Recruiting
Active & Responsive
Type 1 Diabetes Extension Study
for
Type 1 Diabetes Mellitus, T1DM, T1D
Location: Seattle WA, San Francisco CA, Stanford CA, Aurora CO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 8 - 35
Code: NCT02734277
Recruiting
Active & ResponsiveNew
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
for
Type 1 Diabetes Mellitus
Location: Seattle WA, Aurora CO, Pittsburgh PA, New York NY,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 4 - 34
Code: NCT07216391
Phase2, Recruiting
Active & Responsive
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
for
Type 1 Diabetes Mellitus
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 8 - 45
Code: NCT07142252
Phase2, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: Bellevue WA, Walnut Creek CA, San Jose CA, Las Vegas NV,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT06830044
Phase3, Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Seattle WA, Edmonds WA, Vancouver WA, Portland OR,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase2, Phase3, Recruiting
Active & Responsive
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
for
Capsular Contracture Associated With Breast Implant,
Location: Seattle WA, Vancouver WA, Reno NV, Draper UT,